Ciclopirox (E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Ciclopirox drug offered from E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.. This Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | ciclopirox |
| SUBSTANCE NAME: | CICLOPIROX OLAMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | LOTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2004-08-06 |
| END MARKETING DATE: | 0000-00-00 |
Ciclopirox HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ciclopirox from E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
| LABELER NAME: | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7.7(mg/mL) |
| START MARKETING DATE: | 2004-08-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0168-0314_ae069f7e-d070-401d-8d1b-3e835d9f48c8 |
| PRODUCT NDC: | 0168-0314 |
| APPLICATION NUMBER: | ANDA076422 |
Other CICLOPIROX OLAMINE Pharmaceutical Manufacturers / Labelers:
